Remission of acromegaly after treatment withdrawal in patients controlled by cabergoline alone or in combination with octreotide: results from a multicenter study. [electronic resource]
Producer: 20170822Description: 523-528 p. digitalISSN:- 1720-8386
- Acromegaly -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cabergoline
- Ergolines -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Octreotide -- administration & dosage
- Prognosis
- Prospective Studies
- Remission Induction
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.